Published: 31. May, 2021

Clinical trial 0204 in 12 healthy volunteers investigating the absolute bioavailability of CT001, reports…

Clinical trial 0204 in 12 healthy volunteers investigating the absolute bioavailability of CT001, reports last subject dosed ahead of timelines. Primary aim of the trial is to demonstrate drug-exposure following nasal administration of CT001 relative to the IV injection of the approved analgesic drugs  

Press_Release Last subject dosed (0204)